The risk predictive values of <scp>UK</scp>‐<scp>PBC</scp> and <scp>GLOBE</scp> scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti‐gp210

Abstract

The UK-PBC and GLOBE scoring systems were good 5-year prognostic predictors in Chinese patients with PBC, especially in anti-gp210+ patients. As a biomarker, anti-gp210 antibody was associated with a more severe cholestatic manifestation and a worse long-term prognosis. The anti-gp210 antibody could be added to further optimise the UK-PBC and GLOBE scoring systems.